FULC
Fulcrum Therapeutics Inc
3.70$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3,017.9% | -2,658.8% | – | 73.6% | – | – | – | – | – | – | – | – | – | |
| 70.0% | 58.3% | – | 0.5% | – | – | – | – | – | – | – | – | – | |
| 492.4% | 396.0% | – | 5.4% | – | – | – | – | – | – | – | – | – | |
| -207.1% | -118.4% | – | -0.1% | – | – | – | – | – | – | – | – | – | |
| 8.6% | 8.8% | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| 2,505.9% | 2,107.2% | – | -15.6% | – | – | – | – | – | – | – | – | – | |
| 15,525.0% | 33.0% | – | 0.5% | – | – | – | – | – | – | – | – | – | |
| -512.0% | -518.6% | – | 58.4% | – | – | – | – | – | – | – | – | – | |
| -3,026.5% | -2,667.6% | – | 73.6% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.